Task Applied Science and Stellenbosch University
Welcome,         Profile    Billing    Logout  
 6 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Diacon, Andreas
Sisonke Boost, NCT05148845: Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.

Recruiting
3b
500000
RoW
Booster vaccine
Wits Health Consortium (Pty) Ltd, National Department of Health of South Africa, National Institute of Communicable Diseases - NICD, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, Fred Hutchinson Cancer Center, Hutchinson Center Research Institute of South Africa (HCRISA), Janssen Vaccines & Prevention B.V., Bio Analytical Research Corporation, Dis-Chem Pharmacy, BioVac, Biocair, Right to Care, Clinical Laboratory Services, Institute of Infectious Disease and Molecular Medicine
SARS CoV 2 Infection
01/22
06/23
NCT05896930: Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Completed
2
134
RoW
Meropenem 6g IV over 6 hours, Ertapenem 1g IM, Meropenem 3g IV, Ertapenem 1g IV, Amoxicillin/CA twice daily, Rifampicin 35 mg/kg, Meropenem 6g IV over 60 minutes, Rifafour e-275, Meropenem 4g IV, Amoxicillin/CA once daily
TASK Applied Science
Pulmonary Tuberculosis
01/21
01/21
NCT04621825: Post Market Surveillance Study to Confirm Safety and Performance of Silicone PHMB Foam

Completed
N/A
187
RoW
ActivHeal Silicone PHMB Foam Adhesive and Non Adhesive dressing.
Advanced Medical Solutions Ltd., Imarc Research, Inc.
Wound
05/24
07/24
Dooley, Kelly
CRUSH-TB, NCT05766267: Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting
2/3
288
Canada, US, RoW
Rifabutin, Delamanid, Deltyba, Bedaquiline, Sirturo, Moxifloxacin, Pyrazinamide, Isoniazid, Rifampin, Ethambutol
Centers for Disease Control and Prevention, Tuberculosis Trials Consortium
Tuberculosis, Pulmonary, Tuberculosis Infection
10/25
12/26
PURGE-C, NCT04042740: Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection

Completed
2
45
US, RoW
Glecaprevir/Pibrentasvir (G/P), Mavyret
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, AbbVie, National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis C Infection, HIV Infection
05/23
08/23
PTK0796-NTM-20203, NCT04922554: Oral Omadacycline Vs. Placebo in Adults with NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Completed
2
66
US
Omadacycline Oral Tablet, Nuzyra, Placebo, placebo tablets
Paratek Pharmaceuticals Inc
Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterial Pulmonary Infection
06/24
07/24
NCT04287049: A Study of Standard Drugs for Mycobacterium Avium Complex

Recruiting
2
30
US
Azithromycin, Zithromax
Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), CHEST Foundation
Mycobacterium Avium Complex
03/25
05/25
INSIGHT, NCT04734652: INSTI's For The Management of HIV-associated TB

Active, not recruiting
2
122
RoW
Biktarvy®, TLD- fixed-drug combination single tablet, Dolutegravir 50mg /Lamivudine 300mg/ Tenofovir 300mg
Centre for the AIDS Programme of Research in South Africa, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Cape Town, Medical Research Council, South Africa
HIV/AIDS, Tuberculosis, Pulmonary
01/24
08/24
RAD-TB, NCT06192160: Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Not yet recruiting
2
315
RoW
Isoniazid, INH, Rifampicin, RIF, Pyrazinamide, PZA, Ethambutol, EMB, Bedaquiline, BDQ, Pretomanid, Pa, Linezolid, LZD, TBI-223, Sutezolid, SZD
National Institute of Allergy and Infectious Diseases (NIAID), TB Alliance
Pulmonary Tuberculosis
03/26
03/27

Download Options